Based on FAM genes, a prognostic signature, consisting of five genes (ACADVL, ACAT1, ACSL3, ADH4 and ECI1), was established, which showed good performance for the prognosis of HBV-associated HCC both in the TCGA cohort and the validation cohort. This evidence concerns the gene ACSL3 and hepatocellular carcinoma.